Aurobindo Pharma Limited has informed the Exchange regarding a revised press release dated January 04, 2023, titled "Eugia Pharma receives USFDA approval for Azacitidine for Injection".
Aurobindo Pharma Limited has informed the Exchange regarding a revised press release dated January 04, 2023, titled "Eugia Pharma receives USFDA approval for Azacitidine for Injection".